Skip to content
Penumbra Logo - en_US
  • Products
    • Neuro
    • Neuro Thrombectomy
    • Neuro Embolization
    • Neuro Access Catheters
    • Neurosurgical
    • Vascular
    • Coronary Thrombectomy
    • Peripheral Thrombectomy
    • Peripheral Embolization
    • Vascular Access
    • All Products
    • — HIDDEN END COL —
    • — HIDDEN COL —
  • Providers
    • Clinical Evidence
    • Meetings & Events
    • — HIDDEN END COL —
    • Cases
    • MRI Compatibility
    • — HIDDEN END COL —
    • Video Resource Library
    • — HIDDEN END COL —
    • S-BAT Info Center
  • Patients
    • Therapies & Conditions
    • — HIDDEN END COL —
    • Impact and Stories
    • — HIDDEN END COL —
    • MRI Compatibility
    • — HIDDEN COL —
    • — HIDDEN END COL —
    • About Us
      • Careers
      • — HIDDEN END COL —
      • Leadership
      • — HIDDEN END COL —
      • Meetings & Events
      • — HIDDEN END COL —
      • Newsroom
        • Blog
        • — HIDDEN END COL —
        • Press Releases
        • — HIDDEN END COL —
        • News
        • — HIDDEN END COL —
        • Investors
          • Press Releases
          • Our ESG Commitment
          • — HIDDEN END COL —
          • Events & Presentations
          • Stock Information
          • — HIDDEN END COL —
          • SEC Filings
          • — HIDDEN END COL —
          • Governance
          • Flag of AustraliaAustralia
          • Flag of EuropeEurope
          • Flag of FranceFrance
          • Flag of United StatesUnited States
          • Flag of Costa RicaCosta Rica
        Contact Us
          • Overview
          • Neuro
          • Neuro Thrombectomy
          • Neuro Embolization
          • Neuro Access Catheters
          • Neurosurgical
          • Vascular
          • Coronary Thrombectomy
          • Peripheral Thrombectomy
          • Peripheral Embolization
          • Vascular Access
          • All Products
          • Overview
          • Clinical Evidence
          • Cases
          • Video Resource Library
          • S-BAT Info Center
          • Meetings & Events
          • MRI Compatibility
          • Overview
          • Therapies & Conditions
          • Our Impact
          • MRI Compatibility
          • Overview
          • Careers
          • Leadership
          • Meetings & Events
          • Overview
          • Blog
          • Press Releases
          • News
          • Overview
          • Press Releases
          • Events & Presentations
          • SEC Filings
          • Governance
          • Our ESG Commitment
          • Stock Information
        • Contact Us
          1. Clinical Evidence
          2. Current page: STRIKE-PE Study

          STRIKE-PE Study

          A Prospective, Multicenter Study of the Indigo® Aspiration System Seeking to Evaluate the Long-Term Safety and Outcomes of Treating Pulmonary Embolism

          CONTACT US
          ⚠️ Indications, Safety, and Warnings
          Strike PE study logo with lungs and lightning bolt
          newspaper icon

          Prospective, Single-Arm

          human icon

          Up To 1500 Patients

          (Expanded from 600 to 1500 patients in July 2024)

          hospital icon

          Global Multicenter Study

          lungs icon

          Acute Intermediate and High-Risk PE

          Evaluate real-world long-term functional outcomes, safety, and performance of the Indigo Aspiration System for the treatment of PE.

          Per the interim results, treatment with CAVT™ showed significant improvement in primary safety and efficacy endpoints and disease-specific and generic QoL measures.

          document icon white

          ClinicalTrials.gov Study Site

          Learn More

          Interim Results (N = 300):1

          Rapid, statistically significant improvements in RV/LV ratio and sPAP while maintaining safety

          RV/LV Ratio Improvement

          26.8%
          (0.40)

          sPAP Improvement

          19.1%
          (10.4 mmHg)

          Low Composite MAE Rate

          2.0%
          (6/300)

          Treatment with Computer Assisted Vacuum Thrombectomy (CAVT) improved both generic and disease-specific QoL measures2

          EQ-5D-5L

          ✔️Improvement

          EQ-5D-5L
          Index Value

          ✔️Improvement

          EQ VAS

          ✔️Improvement

          PEmb-QoL Overall

          ✔️Improvement

          Lightning Flash Subset Analysis (N = 86)1, 3

          Median Thrombectomy

          Timea

          23.0 min
          [19.0-35.0]

          RV/LV Ratio
          Improvement

          27.8%
          (0.40)b

          Composite MAE
          Ratec

          1.2%
          (1/86)d

          Transfusion Required
          before Discharge

          0

          a. First Indigo device insertion to last Indigo device removal.
          b. N=83.
          c. No device-related serious adverse events
          d. Access site hematoma.

          1. Moriarty, J. M. Periprocedural Results of an Interim Analysis of 300 Pulmonary Embolism Patients From the STRIKE-PE Study. Presented at PERT 2024, September 2024
          2. Moriarty JM, Dohad SY, Schiro BJ, Tamaddon H, Heithaus RE, Iliadis EA, Dexter II DJ, Shavelle DM, Leal SRN, Attallah A, West FM, Keeling WB, Sharp AS, Weinberg I, Clinical, Functional, and Quality of Life Outcomes after Computer Assisted Vacuum Thrombectomy for Pulmonary Embolism: Interim Analysis of the STRIKE-PE Study, Journal of Vascular and Interventional Radiology (2024), doi: https://doi.org/10.1016/j.jvir.2024.04.028.
          3. Qanadli S. Periprocedural outcomes of pulmonary embolism patients treated with computer assisted vacuum thrombectomy: interim analysis of the STRIKE-PE study. Presented at: CIRSE 2024; September 2024

          The clinical results presented herein are for informational purposes only, and may not be predictive for all patients. Individual results may vary depending on patient-specific attributes and other factors.

          Want to Learn More?

          Contact us to learn more about CAVT and schedule a demo

          Contact Us

        Subscribe to the latest from Penumbra

        Subscribe

        Subscribe to the latest from Penumbra

        Subscribe

        Subscribe to the latest from Penumbra

        Subscribe
        • Products
        • Vascular
        • Neuro
        • REAL System Resources
        • Quick Links
        • Blog
        • Careers
        • Investors
        Follow Us

        MRI COMPATIBILITY
        MRI COMPATIBILITY

        Legal

        Privacy

        COOKIE SETTINGS

        Copyright ©2026 Penumbra, Inc. All rights reserved.  This website is intended for US audience only.

        Copyright ©2026 Penumbra, Inc. All rights reserved. 

        Copyright ©2026 Penumbra, Inc. All rights reserved.

        Copyright ©2026 Penumbra, Inc. All rights reserved. 

        For more information on the personal data that is collected by this website, please refer to Penumbra’s Privacy Notice.

        CME Opportunities

        Interested in attending a Penumbra medical education event?

        Learn More